Back to search

Article

Effects of Cholesterol Modulation on Cisplatin-Induced Hearing Loss

2025-09-26

Abstract excerpt

<h4>ABSTRACT</h4> Cisplatin is a widely used and effective anticancer drug. However, it causes permanent sensorineural hearing loss in over 50% of treated patients. There are no FDA-approved therapies to prevent cisplatin-induced hearing loss (CIHL) in adults, highlighting a critical unmet clinical need. Previous studies suggest that statins, commonly prescribed cholesterol-lowering drugs, are associated with red...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ecfdc584-3acb-5311-9719-c0661337694c
DOI
10.1101/2025.09.23.678043
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Effects of Cholesterol Modulation on Cisplatin-Induced Hearing LossDOI 10.1101/2025.09.23.678043
Select a neighboring publication to make it the new centre.